Catherine Bearce Nowak, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Disabled Children | 1 | 2015 | 247 | 0.440 |
Why?
|
Neurocutaneous Syndromes | 1 | 2007 | 51 | 0.290 |
Why?
|
Child Abuse | 1 | 2015 | 1030 | 0.290 |
Why?
|
Growth Disorders | 2 | 2021 | 645 | 0.250 |
Why?
|
Developmental Disabilities | 4 | 2023 | 1456 | 0.240 |
Why?
|
Mutation, Missense | 4 | 2024 | 2564 | 0.230 |
Why?
|
Spliceosomes | 1 | 2024 | 110 | 0.230 |
Why?
|
Nervous System Malformations | 2 | 2022 | 247 | 0.220 |
Why?
|
GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2022 | 89 | 0.210 |
Why?
|
Chromosome Aberrations | 3 | 2010 | 1813 | 0.210 |
Why?
|
Hypertrichosis | 1 | 2021 | 25 | 0.200 |
Why?
|
Eye Abnormalities | 1 | 2023 | 246 | 0.190 |
Why?
|
Transaldolase | 1 | 2020 | 9 | 0.190 |
Why?
|
Transketolase | 1 | 2020 | 9 | 0.190 |
Why?
|
Ethers | 1 | 2020 | 75 | 0.190 |
Why?
|
Carbohydrate Metabolism, Inborn Errors | 1 | 2020 | 31 | 0.190 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2020 | 88 | 0.190 |
Why?
|
Haploinsufficiency | 2 | 2020 | 328 | 0.180 |
Why?
|
Genes, Dominant | 2 | 2020 | 880 | 0.170 |
Why?
|
Parkinsonian Disorders | 1 | 2022 | 275 | 0.170 |
Why?
|
NFI Transcription Factors | 1 | 2018 | 44 | 0.170 |
Why?
|
Dystonia | 1 | 2022 | 363 | 0.160 |
Why?
|
Skin Diseases | 1 | 2007 | 1065 | 0.160 |
Why?
|
Movement Disorders | 1 | 2022 | 445 | 0.160 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2021 | 294 | 0.160 |
Why?
|
Spastic Paraplegia, Hereditary | 1 | 2020 | 157 | 0.160 |
Why?
|
Metabolism, Inborn Errors | 1 | 2020 | 288 | 0.160 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 113 | 0.160 |
Why?
|
Phenotype | 9 | 2023 | 16365 | 0.160 |
Why?
|
Dystonic Disorders | 1 | 2022 | 329 | 0.160 |
Why?
|
Language Disorders | 1 | 2018 | 141 | 0.150 |
Why?
|
Speech Disorders | 1 | 2018 | 189 | 0.150 |
Why?
|
Epilepsy | 3 | 2018 | 3310 | 0.150 |
Why?
|
Adaptor Protein Complex beta Subunits | 1 | 2016 | 13 | 0.150 |
Why?
|
Adaptor Protein Complex 3 | 1 | 2016 | 17 | 0.150 |
Why?
|
Aggrecans | 1 | 2017 | 90 | 0.150 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 173 | 0.150 |
Why?
|
Nervous System Diseases | 1 | 2007 | 1622 | 0.140 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2021 | 670 | 0.140 |
Why?
|
Portraits as Topic | 1 | 2016 | 33 | 0.140 |
Why?
|
Abnormalities, Multiple | 2 | 2007 | 1416 | 0.140 |
Why?
|
Optic Atrophy | 1 | 2016 | 79 | 0.140 |
Why?
|
Dwarfism | 1 | 2017 | 146 | 0.130 |
Why?
|
Connective Tissue Diseases | 1 | 1998 | 264 | 0.130 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 736 | 0.130 |
Why?
|
Mandatory Reporting | 1 | 2015 | 121 | 0.120 |
Why?
|
Choriocarcinoma | 1 | 2014 | 126 | 0.120 |
Why?
|
Genes, Recessive | 1 | 2016 | 641 | 0.120 |
Why?
|
Endolymphatic Sac | 1 | 2014 | 50 | 0.120 |
Why?
|
Hemangioblastoma | 1 | 2014 | 70 | 0.120 |
Why?
|
Ear Neoplasms | 1 | 2014 | 117 | 0.120 |
Why?
|
Zebrafish | 2 | 2022 | 2994 | 0.110 |
Why?
|
Genetic Diseases, Inborn | 2 | 2016 | 587 | 0.110 |
Why?
|
Genetics, Medical | 1 | 2016 | 338 | 0.110 |
Why?
|
DNA Helicases | 1 | 2018 | 859 | 0.110 |
Why?
|
von Hippel-Lindau Disease | 1 | 2014 | 152 | 0.110 |
Why?
|
Vertigo | 1 | 2014 | 202 | 0.110 |
Why?
|
Exons | 1 | 2018 | 2437 | 0.100 |
Why?
|
Hearing Loss, Sensorineural | 1 | 1998 | 770 | 0.100 |
Why?
|
Tinnitus | 1 | 2014 | 195 | 0.100 |
Why?
|
Postpartum Hemorrhage | 1 | 2015 | 258 | 0.100 |
Why?
|
Histones | 1 | 2022 | 2599 | 0.100 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2703 | 0.100 |
Why?
|
Uterus | 1 | 2015 | 711 | 0.100 |
Why?
|
Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2010 | 13 | 0.090 |
Why?
|
Syndrome | 4 | 2022 | 3251 | 0.090 |
Why?
|
Lissencephaly | 1 | 2010 | 38 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2849 | 0.090 |
Why?
|
Child, Preschool | 11 | 2023 | 41006 | 0.090 |
Why?
|
Suture Techniques | 1 | 2015 | 798 | 0.090 |
Why?
|
Mutation | 4 | 2017 | 29786 | 0.090 |
Why?
|
Lipids | 1 | 2020 | 3305 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1903 | 0.080 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2010 | 437 | 0.080 |
Why?
|
Child | 12 | 2023 | 77709 | 0.080 |
Why?
|
Pregnancy Outcome | 2 | 2015 | 2795 | 0.080 |
Why?
|
Cardiovascular Abnormalities | 1 | 2008 | 144 | 0.080 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2008 | 351 | 0.080 |
Why?
|
Hearing Loss | 1 | 2014 | 765 | 0.070 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2007 | 111 | 0.070 |
Why?
|
Sturge-Weber Syndrome | 1 | 2007 | 91 | 0.070 |
Why?
|
Infant | 8 | 2023 | 35136 | 0.070 |
Why?
|
Uterine Neoplasms | 1 | 2014 | 1513 | 0.060 |
Why?
|
HEK293 Cells | 3 | 2018 | 4204 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12208 | 0.060 |
Why?
|
Humans | 27 | 2024 | 744343 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4462 | 0.060 |
Why?
|
Female | 19 | 2023 | 380194 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2018 | 13033 | 0.050 |
Why?
|
Pedigree | 3 | 2017 | 4644 | 0.050 |
Why?
|
Anterior Eye Segment | 1 | 2023 | 152 | 0.050 |
Why?
|
Male | 17 | 2023 | 350118 | 0.050 |
Why?
|
Neurofibromatosis 1 | 1 | 2007 | 569 | 0.050 |
Why?
|
DNA Repair Enzymes | 1 | 2024 | 349 | 0.050 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 449 | 0.050 |
Why?
|
Failure to Thrive | 1 | 2021 | 136 | 0.050 |
Why?
|
Pentose Phosphate Pathway | 1 | 2020 | 124 | 0.050 |
Why?
|
Histone Demethylases | 1 | 2022 | 321 | 0.040 |
Why?
|
Down Syndrome | 1 | 2008 | 880 | 0.040 |
Why?
|
Vomiting | 1 | 2023 | 636 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17446 | 0.040 |
Why?
|
RNA Splicing | 1 | 2024 | 907 | 0.040 |
Why?
|
Chromosome Deletion | 2 | 2016 | 1401 | 0.040 |
Why?
|
RNA Transport | 1 | 2018 | 48 | 0.040 |
Why?
|
Nuclear Proteins | 2 | 2024 | 5853 | 0.040 |
Why?
|
Young Adult | 6 | 2023 | 56430 | 0.040 |
Why?
|
Adolescent | 7 | 2023 | 85781 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 2018 | 281 | 0.040 |
Why?
|
Face | 1 | 2022 | 994 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 976 | 0.040 |
Why?
|
Constipation | 1 | 2021 | 546 | 0.030 |
Why?
|
Chromosome Duplication | 1 | 2016 | 74 | 0.030 |
Why?
|
Genes, X-Linked | 1 | 2016 | 128 | 0.030 |
Why?
|
Uterine Inertia | 1 | 2015 | 29 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 1998 | 514 | 0.030 |
Why?
|
Osteochondritis Dissecans | 1 | 2017 | 111 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 927 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2024 | 1708 | 0.030 |
Why?
|
Growth | 1 | 2017 | 376 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 1970 | 0.030 |
Why?
|
Dactinomycin | 1 | 2014 | 318 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2018 | 839 | 0.030 |
Why?
|
Adult | 9 | 2023 | 214055 | 0.030 |
Why?
|
Growth Hormone | 1 | 2017 | 705 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2020 | 1005 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2022 | 12072 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2018 | 635 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2023 | 2421 | 0.030 |
Why?
|
Corpus Callosum | 1 | 2018 | 737 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11524 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1730 | 0.030 |
Why?
|
Genetic Variation | 2 | 2020 | 6544 | 0.030 |
Why?
|
Etoposide | 1 | 2014 | 641 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2020 | 2203 | 0.030 |
Why?
|
Aneuploidy | 1 | 2016 | 530 | 0.030 |
Why?
|
Chorionic Gonadotropin | 1 | 2014 | 477 | 0.030 |
Why?
|
Microcephaly | 1 | 2016 | 432 | 0.030 |
Why?
|
Anthropometry | 1 | 2017 | 1350 | 0.030 |
Why?
|
Glutamic Acid | 1 | 2017 | 1169 | 0.030 |
Why?
|
HeLa Cells | 1 | 2018 | 3128 | 0.030 |
Why?
|
Metabolomics | 1 | 2020 | 1484 | 0.030 |
Why?
|
Drosophila melanogaster | 1 | 2020 | 1708 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2020 | 1703 | 0.020 |
Why?
|
Segmental Duplications, Genomic | 1 | 2010 | 19 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2023 | 77449 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2934 | 0.020 |
Why?
|
Heterozygote | 1 | 2017 | 2804 | 0.020 |
Why?
|
History, 21st Century | 1 | 2016 | 1534 | 0.020 |
Why?
|
Age of Onset | 1 | 2016 | 3271 | 0.020 |
Why?
|
Neurons | 2 | 2020 | 9338 | 0.020 |
Why?
|
Models, Molecular | 1 | 2018 | 5456 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9386 | 0.020 |
Why?
|
Cisplatin | 1 | 2014 | 1662 | 0.020 |
Why?
|
History, 20th Century | 1 | 2016 | 2740 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4186 | 0.020 |
Why?
|
Methotrexate | 1 | 2014 | 1727 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7301 | 0.020 |
Why?
|
Animals | 4 | 2022 | 168757 | 0.020 |
Why?
|
Craniofacial Abnormalities | 1 | 2010 | 315 | 0.020 |
Why?
|
Pregnancy | 3 | 2015 | 29144 | 0.020 |
Why?
|
Brain | 3 | 2022 | 26385 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8436 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2016 | 25625 | 0.020 |
Why?
|
Gestational Age | 1 | 2014 | 3493 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7799 | 0.020 |
Why?
|
Genetic Counseling | 1 | 2008 | 600 | 0.020 |
Why?
|
Prognosis | 2 | 2015 | 29063 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12951 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14557 | 0.010 |
Why?
|
Reproduction | 1 | 2008 | 668 | 0.010 |
Why?
|
Genetic Testing | 1 | 2016 | 3444 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15997 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2018 | 5708 | 0.010 |
Why?
|
Seizures | 1 | 2014 | 2859 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3920 | 0.010 |
Why?
|
Mice | 2 | 2018 | 81183 | 0.010 |
Why?
|
Middle Aged | 3 | 2023 | 213383 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 21827 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15519 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 40561 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23403 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2015 | 15295 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2017 | 57776 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 72290 | 0.010 |
Why?
|
United States | 1 | 2016 | 69872 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2014 | 63114 | 0.000 |
Why?
|
Aged | 1 | 2017 | 163280 | 0.000 |
Why?
|